Management of Cytomegalovirus Infection and Disease after Solid‐Organ Transplantation
Open Access
- 1 July 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (s1) , S32-S37
- https://doi.org/10.1086/320902
Abstract
Cytomegalovirus (CMV) continues to be a cause of substantial morbidity and death after solid-organ transplantation. There are 3 major consequences ofKeywords
This publication has 44 references indexed in Scilit:
- PREEMPTIVE TREATMENT FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASETransplantation, 1998
- COMPARISON OF POLYMERASE CHAIN REACTION FROM PLASMA AND BUFFY COAT WITH ANTIGEN DETECTION AND OCCURRENCE OF IMMUNOGLOBULIN M FOR THE DEMONSTRATION OF CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATIONTransplantation, 1995
- PROVISION OF PROGNOSTIC INFORMATION IN IMMUNOCOMPROMISED PATIENTS BY ROUTINE APPLICATION OF THE POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUSTransplantation, 1993
- EARLY DIAGNOSIS OF HUMAN CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS BY DNA AMPLIFICATION IN PLASMATransplantation, 1993
- A longitudinal prospective study of cytomegalovirus pp65 antigenemia in renal transplant recipientsTransplant International, 1993
- CYTOMEGALOVIRUS ANTIGENEMIA AS A USEFUL MARKER OF SYMPTOMATIC CYTOMEGALOVIRUS INFECTION AFTER RENAL TRANSPLANTATION—A REPORT OF 130 CONSECUTIVE PATIENTSTransplantation, 1989
- PREVENTION OF CYTOMEGALOVIRUS-RELATED DEATH BY PASSIVE IMMUNIZATIONTransplantation, 1989
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- Screening tests for antibodies to cytomegalovirus: an evaluation of five commercial products.Journal of Clinical Pathology, 1985
- Glomerulopathy Associated with Cytomegalovirus Viremia in Renal AllograftsNew England Journal of Medicine, 1981